BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7351492)

  • 21. Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension.
    Hartmann A; Broecker EB; Hamm H
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):624-6. PubMed ID: 18410624
    [No Abstract]   [Full Text] [Related]  

  • 22. Acral lesions of vitiligo: why are they resistant to photochemotherapy?
    Esmat SM; El-Tawdy AM; Hafez GA; Zeid OA; Abdel Halim DM; Saleh MA; Leheta TM; Elmofty M
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1097-104. PubMed ID: 21851425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repigmentation through Melanocyte Regeneration in Vitiligo.
    Birlea SA; Goldstein NB; Norris DA
    Dermatol Clin; 2017 Apr; 35(2):205-218. PubMed ID: 28317529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation.
    Nishimura EK
    Pigment Cell Melanoma Res; 2011 Jun; 24(3):401-10. PubMed ID: 21466661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitiligo treated by psoralens. A long-term follow-up study of the permanency of repigmentation.
    Kenney JA
    Arch Dermatol; 1971 May; 103(5):475-80. PubMed ID: 5580287
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model.
    Faas L; Venkatasamy R; Hider RC; Young AR; Soumyanath A
    Br J Dermatol; 2008 May; 158(5):941-50. PubMed ID: 18284389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of melanoblasts and melanocytes after treatment with monochromatic excimer light and narrowband-ultraviolet B of skin of vitiligo patients.
    Hirobe T; Enami H
    Int J Dermatol; 2019 Feb; 58(2):210-217. PubMed ID: 30191560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced Elastin Fibers and Melanocyte Loss in Vitiliginous Skin Are Restored after Repigmentation by Phototherapy and/or Autologous Minigraft Transplantation.
    Hirobe T; Enami H
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repigmentation of Human Vitiligo Skin by NBUVB Is Controlled by Transcription of GLI1 and Activation of the β-Catenin Pathway in the Hair Follicle Bulge Stem Cells.
    Goldstein NB; Koster MI; Jones KL; Gao B; Hoaglin LG; Robinson SE; Wright MJ; Birlea SI; Luman A; Lambert KA; Shellman YG; Fujita M; Robinson WA; Roop DR; Norris DA; Birlea SA
    J Invest Dermatol; 2018 Mar; 138(3):657-668. PubMed ID: 29054607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistopathological analysis of frizzled-4-positive immature melanocytes from hair follicles of patients with Rhododenol-induced leukoderma.
    Okamura K; Ohe R; Abe Y; Ueki M; Hozumi Y; Tamiya G; Matsunaga K; Yamakawa M; Suzuki T
    J Dermatol Sci; 2015 Nov; 80(2):156-8. PubMed ID: 26277630
    [No Abstract]   [Full Text] [Related]  

  • 31. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes?
    Davids LM; du Toit E; Kidson SH; Todd G
    Clin Exp Dermatol; 2009 Mar; 34(2):246-8. PubMed ID: 18828846
    [No Abstract]   [Full Text] [Related]  

  • 32. Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization.
    Birlea SA; Costin GE; Roop DR; Norris DA
    Med Res Rev; 2017 Jul; 37(4):907-935. PubMed ID: 28029168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of optimal topical photochemotherapy for vitiligo.
    Grimes PE; Minus HR; Chakrabarti SG; Enterline J; Halder R; Gough JE; Kenney JA
    J Am Acad Dermatol; 1982 Dec; 7(6):771-8. PubMed ID: 7174915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral photochemotherapy in vitiligo (author's transl)].
    Ortonne JP; Sannwald C; Thivolet J
    Ann Dermatol Venereol; 1978; 105(6-7):617-24. PubMed ID: 736430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study.
    Kwok YK; Anstey AV; Hawk JL
    Clin Exp Dermatol; 2002 Mar; 27(2):104-10. PubMed ID: 11952699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repigmentation of vitiligo during efalizumab.
    Wakkee M; Assen YJ; Thio HB; Neumann HA
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S57-8. PubMed ID: 18625392
    [No Abstract]   [Full Text] [Related]  

  • 37. PUVA treatment of vitiligo: a retrospective study of Turkish patients.
    Sahin S; Hindioğlu U; Karaduman A
    Int J Dermatol; 1999 Jul; 38(7):542-5. PubMed ID: 10440288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pigmentary response to photochemotherapy.
    Zaynoun S; Konrad K; Gschnait F; Wolff K
    Acta Derm Venereol; 1977; 57(5):431-40. PubMed ID: 73310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repigmentation of poliosis after epithelial grafting for vitiligo.
    Awad SS
    Dermatol Surg; 2013 Mar; 39(3 Pt 1):406-11. PubMed ID: 23294472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous epidermal grafting with PUVA-irradiated donor skin for the treatment of vitiligo.
    Lee AY; Jang JH
    Int J Dermatol; 1998 Jul; 37(7):551-4. PubMed ID: 9679700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.